SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorHanoi Medical University

About this trial

This randomized controlled trial compares the airway management performance of the SafeLM video laryngeal mask with the LMA Classic in adult patients undergoing elective fibroadenoma excision under general anesthesia. Participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic. The primary outcome is oropharyngeal leak pressure. Secondary outcomes include insertion performance, ventilation parameters, hemodynamic responses, and airway-related adverse events.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female patients aged 18 years or older.

Scheduled for elective excision of benign breast fibroadenoma under general anesthesia.

Planned airway management with a laryngeal mask airway.

American Society of Anesthesiologists (ASA) physical status I-II.

Disqualifiers

Increased risk of pulmonary aspiration, including inadequate preoperative fasting, full stomach, or gastrointestinal obstruction.

Known or suspected difficult airway or other airway characteristics for which random allocation between the two study devices is considered clinically inappropriate.

Upper airway pathology or anatomical abnormality that may interfere with laryngeal mask placement.

Clinical or surgical indication requiring tracheal intubation rather than a laryngeal mask airway.

Trial design

Design model

Parallel

Treatments tested in this trial

  • SafeLM Video Laryngeal Mask

    Device

    The SafeLM is a video-assisted supraglottic airway device that allows visualization of the laryngeal structures during insertion and positioning. It will be used for airway management during general anesthesia according to the standardized study protocol.

  • LMA Classic

    Device

    The LMA Classic is a conventional supraglottic airway device without video guidance. It will be used for airway management during general anesthesia according to the standardized study protocol.

Treatment groups

132 Participants
are divided into 2 treatment groups
Group A: SafeLM Video Laryngeal MaskExperimental treatment 1 intervention
Group B: LMA ClassicActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Oropharyngeal Leak Pressure (OLP)

Oropharyngeal leak pressure will be measured after successful placement of the assigned laryngeal mask and establishment of effective ventilation. OLP will be recorded in cmH2O as the airway pressure at which an audible oropharyngeal leak is detected during a standardized leak test.

Time frame
Immediately after successful laryngeal mask placement, before the start of surgery

Secondary outcomes

1

First-attempt insertion success

Proportion of participants in whom effective ventilation is achieved after the first insertion attempt of the assigned laryngeal mask.

Time frame
During initial laryngeal mask insertion
2

Overall insertion success

Proportion of participants in whom effective ventilation is achieved with the assigned laryngeal mask within the maximum number of insertion attempts permitted by the study protocol.

Time frame
During laryngeal mask insertion, up to 3 attempts
3

Laryngeal mask insertion time

Time in seconds from introduction of the assigned laryngeal mask into the mouth until establishment of effective ventilation.

Time frame
During laryngeal mask insertion
4

Number of insertion attempts

Number of attempts required to achieve successful placement and effective ventilation with the assigned laryngeal mask.

Time frame
During laryngeal mask insertion

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: